SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-006331
Filing Date
2023-09-07
Accepted
2023-09-07 16:05:28
Documents
15
Period of Report
2023-08-31
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm   iXBRL 8-K 31730
2 CERTIFICATE OF CHANGE TO ARTICLES OF INCORPORATION pharmacyte_ex0301.htm EX-3.1 3385
3 GRAPHIC image_001.jpg GRAPHIC 99078
4 GRAPHIC image_002.jpg GRAPHIC 208042
  Complete submission text file 0001683168-23-006331.txt   636056

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pmcb-20230831.xsd EX-101.SCH 3079
6 XBRL LABEL FILE pmcb-20230831_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE pmcb-20230831_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3412
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 231242279
SIC: 2836 Biological Products, (No Diagnostic Substances)